- Home
- DRMA vs EVOK Comparison
DRMA vs EVOK Comparison
Compare DRMA & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- EVOK
- Stock Information
- Founded
- DRMA 2014
- EVOK 2007
- Country
- DRMA United States
- EVOK United States
- Employees
- DRMA N/A
- EVOK N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- DRMA Health Care
- EVOK Health Care
- Exchange
- DRMA Nasdaq
- EVOK Nasdaq
- Market Cap
- DRMA 6.1M
- EVOK 7.1M
- IPO Year
- DRMA 2021
- EVOK 2013
- Fundamental
- Price
- DRMA $1.25
- EVOK $5.07
- Analyst Decision
- DRMA Strong Buy
- EVOK
- Analyst Count
- DRMA 1
- EVOK 0
- Target Price
- DRMA $6.00
- EVOK N/A
- AVG Volume (30 Days)
- DRMA 465.7K
- EVOK 8.5K
- Earning Date
- DRMA 03-20-2025
- EVOK 03-13-2025
- Dividend Yield
- DRMA N/A
- EVOK N/A
- EPS Growth
- DRMA N/A
- EVOK N/A
- EPS
- DRMA N/A
- EVOK N/A
- Revenue
- DRMA N/A
- EVOK $8,617,036.00
- Revenue This Year
- DRMA N/A
- EVOK $97.35
- Revenue Next Year
- DRMA N/A
- EVOK $99.52
- P/E Ratio
- DRMA N/A
- EVOK N/A
- Revenue Growth
- DRMA N/A
- EVOK 100.35
- 52 Week Low
- DRMA $1.00
- EVOK $3.54
- 52 Week High
- DRMA $7.62
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- DRMA 52.68
- EVOK 55.10
- Support Level
- DRMA $1.00
- EVOK $4.68
- Resistance Level
- DRMA $1.28
- EVOK $5.40
- Average True Range (ATR)
- DRMA 0.09
- EVOK 0.31
- MACD
- DRMA 0.01
- EVOK 0.03
- Stochastic Oscillator
- DRMA 74.07
- EVOK 57.85
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.